Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ataxin-1 (Homo sapiens (Human)) | BDBM50233168![]() (CHEMBL4085965 | US11124490, Compound 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 9.32 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233154![]() (CHEMBL4096134 | US11124490, Compound 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 31.5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233173![]() (CHEMBL4094366 | US11124490, Compound 14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 35.3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233166![]() (CHEMBL4060128 | US11124490, Compound 3g) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 40.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233155![]() (CHEMBL4080953 | US11124490, Compound 28b) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 55.5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233157![]() (CHEMBL4097500 | US11124490, Compound 28a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 66.9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233170![]() (CHEMBL4073772 | US11124490, Compound 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 67.3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233171![]() (CHEMBL4099620 | US11124490, Compound 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 83.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233169![]() (CHEMBL4082022 | US11124490, Compound 3f) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 83.7 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233164![]() (CHEMBL4105201 | US11124490, Compound 29) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50187687![]() (CHEMBL3828733 | US11124490, Compound 918013) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 117 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233163![]() (CHEMBL4102111 | US11124490, Compound 12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 121 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233160![]() (CHEMBL4071490 | US11124490, Compound 3h) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233168![]() (CHEMBL4085965 | US11124490, Compound 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 396 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233188![]() (CHEMBL4098521 | US11124490, Compound 3i) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 864 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233154![]() (CHEMBL4096134 | US11124490, Compound 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233183![]() (CHEMBL4091756 | US11124490, Compound 3e) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233177![]() (CHEMBL4070890 | US11124490, Compound 3d) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM517730![]() (US11124490, Compound 4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233159![]() (CHEMBL4072723 | US11124490, Compound 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233167![]() (CHEMBL4091887 | US11124490, Compound 20) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233184![]() (CHEMBL4064138 | US11124490, Compound 22) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233186![]() (CHEMBL4070002 | US11124490, Compound 23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233185![]() (CHEMBL4090985 | US11124490, Compound 25) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233156![]() (CHEMBL4070321 | US11124490, Compound 26a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM50233168![]() (CHEMBL4085965 | US11124490, Compound 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound 3b was found to be the most potent ATX inhibitor with an IC50 of about 9 nM. The mechanism of action was determined to be competitive; howev... | Citation and Details BindingDB Entry DOI: 10.7270/Q29Z982P | |||||||||||
More data for this Ligand-Target Pair |